NRIX vs STE · rev $54.5M vs P/E 25, rev $5.46B
Nurix Therapeutics Inc (NRIX) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
NRIX currently screens at market cap $1.77B. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the NRIX and STE stock pages for the full models.
Not investment advice.